Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	277.38	-37.33	9.89
Graham Fair Price	-51.30	175.58	360.56
PEG	4584.50	-0.11	< 0.005
Price/Book	17.43	1.24	1.06
Price/Cash Flow	186.11	17.77	-6.21
Prices/Earnings	416.11	8.12	1.57
Price/Sales	51.72	4.70	3.10
Price/FCF	186.11	17.77	-6.21
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.89	1.01	1.00
Operating Margin	-13.76	0.28	0.32
ROA	-77.33	< 0.005	0.03
ROE	0.17	0.04	-77.25
ROIC	0.13	0.06	-52.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.04	-5.79
Dividends QOQ	< 0.005	< 0.005	-17.56
EBIT QOQ	123789.64	-0.31	-100.00
EPS QOQ	7.01	-0.77	-88.98
FCF QOQ	-2.46	1.43	-42.10
Revenue QOQ	0.77	-0.20	-74.14
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-121113.91	228284.25	88.49
Days Sales Outstanding (DSO)	369.70	508.03	37.42
Inventory Turnover	< 0.005	< 0.005	-46.95
Debt/Capitalization	0.17	0.16	-5.96
Quick Ratio	6.05	6.21	2.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	185.62	189.50	2.09
Cash	127.25	120.86	-5.02
Capex	-41.62	0.00	inf
Free Cash Flow	-31.56	13.23	-58.10
Revenue	63.31	50.03	-20.98
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.05	0.48	-92.08
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.08	-0.83	946.55
Naive Interpretation	Member

06 - Financial Health · Bad

Rating